International Stem Cell Corporation (ISCO) Uses Multiple Business Units to Generate Even More Revenue
International Stem Cell Corporation (OTC: ISCO) focuses on utilizing patented human parthenogenetic stem cells (hPSC), developed from unfertilized embryos, to…